Literature DB >> 23982880

Comprehensive assessment of the association between DNA repair gene XRCC3 rs861539 C/T polymorphism and lung cancer risk.

Gang Ding1, Weiguo Xu, Hongwei Hua, Qian Huang, Hongxiang Liang, Yufeng Ni, Zhaoheng Ding.   

Abstract

A few case-control studies were performed to assess the association between X-ray repair cross-complementing group 3 (XRCC3) rs861539 C/T polymorphism and lung cancer susceptibility, but no consistent finding was reported. In the present study, we performed a meta-analysis of 14 case-control studies with a total of 7,869 lung cancer cases and 10,778 controls to provide a comprehensive assessment of the association between XRCC3 rs861539 C/T polymorphism and lung cancer risk. Pooled odds ratios (ORs) and corresponding 95 % confidence intervals (95 % CIs) were calculated to assess the strength of the association. Overall, there was no significant association between XRCC3 rs861539 C/T polymorphism and lung cancer risk under all genetic models [OR (95 % CI) for T versus C, 1.00 (0.89-1.13), P = 0.99; OR (95 % CI) for TT versus CC, 1.07 (0.81-1.41), P = 0.62; OR (95 % CI) for TT/CT versus CC, 0.95 (0.84-1.07), P = 0.39; OR (95 % CI) for TT versus CT/CC, 1.10 (0.86-1.39), P = 0.62]. In the subgroup analyses of both Asians and Caucasians, there was still no significant association between XRCC3 rs861539 C/T polymorphism and lung cancer risk under all genetic models (All P values were more than 0.05). However, there was an obvious association between XRCC3 rs861539 C/T polymorphism and decreased risk of lung cancer in the subgroup analysis of the mixed population (All P values were less than 0.05). In addition, there was some risk of publication bias in the meta-analysis, and there was obvious discrepancy in the findings between studies with large sample size and studies with small sample size in the meta-analysis. The meta-analysis indicates that the association between XRCC3 rs861539 C/T polymorphism and lung cancer risk is still uncertain owing to the obvious discrepancy in the findings between studies with large sample size and studies with small sample size. More studies with large sample size are needed to further assess the association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23982880     DOI: 10.1007/s13277-013-0705-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  30 in total

Review 1.  Lung cancer.

Authors:  Roy S Herbst; John V Heymach; Scott M Lippman
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

Review 2.  Genetic susceptibility to cancer: the role of polymorphisms in candidate genes.

Authors:  Linda M Dong; John D Potter; Emily White; Cornelia M Ulrich; Lon R Cardon; Ulrike Peters
Journal:  JAMA       Date:  2008-05-28       Impact factor: 56.272

3.  DNA repair polymorphisms and cancer risk in non-smokers in a cohort study.

Authors:  G Matullo; A M Dunning; S Guarrera; C Baynes; S Polidoro; S Garte; H Autrup; C Malaveille; M Peluso; L Airoldi; F Veglia; E Gormally; G Hoek; M Krzyzanowski; K Overvad; O Raaschou-Nielsen; F Clavel-Chapelon; J Linseisen; H Boeing; A Trichopoulou; D Palli; V Krogh; R Tumino; S Panico; H B Bueno-De-Mesquita; P H Peeters; E Lund; G Pera; C Martinez; M Dorronsoro; A Barricarte; M J Tormo; J R Quiros; N E Day; T J Key; R Saracci; R Kaaks; E Riboli; P Vineis
Journal:  Carcinogenesis       Date:  2005-11-23       Impact factor: 4.944

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  DNA repair gene XRCC3 T241M polymorphism and bladder cancer risk in a Chinese population.

Authors:  Xuan Zhu; Zhaohui Zhong; Xuanzhi Zhang; Xiaokun Zhao; Ran Xu; Weigang Ren; Songchao Li
Journal:  Genet Test Mol Biomarkers       Date:  2012-02-02

6.  Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population.

Authors:  Chikako Kiyohara; Takahiko Horiuchi; Koichi Takayama; Yoichi Nakanishi
Journal:  J Thorac Oncol       Date:  2012-06       Impact factor: 15.609

7.  Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland.

Authors:  R Rita Misra; Duminda Ratnasinghe; Joseph A Tangrea; Jarmo Virtamo; Mark R Andersen; Michael Barrett; Philip R Taylor; Demetrius Albanes
Journal:  Cancer Lett       Date:  2003-03-10       Impact factor: 8.679

8.  MMP1-1607 1G/2G polymorphism and lung cancer risk: a meta-analysis.

Authors:  Xu-Yang Xiao; Xiao-Dong Wang; Dong-Yu Zang
Journal:  Tumour Biol       Date:  2012-09-11

9.  Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.

Authors:  Ming Yin; Zhongxing Liao; Yu-Jing Huang; Zhensheng Liu; Xianglin Yuan; Daniel Gomez; Li-E Wang; Qingyi Wei
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

10.  Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.

Authors:  M Felicitas López-Cima; Patricia González-Arriaga; Laura García-Castro; Teresa Pascual; Manuel G Marrón; Xose S Puente; Adonina Tardón
Journal:  BMC Cancer       Date:  2007-08-16       Impact factor: 4.430

View more
  2 in total

1.  Association between XRCC3 Thr241Met polymorphism and nasopharyngeal carcinoma risk: evidence from a large-scale case-control study and a meta-analysis.

Authors:  Qian Cui; Xiao-Yu Zuo; Yi-Fan Lian; Qi-Sheng Feng; Yun-Fei Xia; Cai-Yun He; Li-Zhen Chen; Wei-Hua Jia; Hai-Qiang Mai; Yi-Xin Zeng; Jin-Xin Bei
Journal:  Tumour Biol       Date:  2016-09-17

2.  Homologous Recombination Repair Polymorphisms and the Risk for Osteosarcoma.

Authors:  Katja Goričar; Viljem Kovač; Janez Jazbec; Janez Lamovec; Vita Dolžan
Journal:  J Med Biochem       Date:  2015-03-03       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.